Nippon India Pharma Fund Review

0 139

Nippon India (Reliance) Pharma Fund Review

In this article, we are going to review the Nippon India Pharma Fund. It’s primarily being cyclical mutual funds, which invest in the Pharma sector.  There are other associated companies with a focus on an important segment of the sector like domestic business, international & CRAMS, which include high growth pharma business.  

Age of the Fund :  

The fund was launched on 5th June 2004. The age of the fund is more than 15 years, which is a testimony of the investor’s confidence in the fund. The age provides you a glimpse of how many bull cycles and bear cycles it survived. Age is not the only factor in it.  

Return and RiskAdjusted Returns: 

The prime purpose of any investment is to get a good return without taking much risk. The fund has beaten the benchmark in two- and five-year time period. The risk associated with these funds is extremely high. So, before making any investment in this fund, one must calculate the risk of their risk-taking ability.  

Nippon India Pharma Fund Growth

The Expense ratio of Nippon India Pharma Fund: 

The expense ratio is one of the most important things to be taken into consideration. It is money to be paid to the fund manager, maintenance fees as well as marketing fees. There is a general notion that the expense ratio is typically higher when the AUM is slow. The expense ratio of the Nippon India Pharma fund is 1.36%. The best way to judge your own expense ratio is by comparing other funds in the same category.  

  • DSP INDIA Tiger Fund  has  an AUM of Rs. 1,089.99 crores have an expense ratio of 1.83%.  
  • UTP Transportation and Logistics Fund have an asset size of 1,422.22 crores and the expense ratio of 1.32%.  
  • L&T Infrastructure Fund has an Aum of Rs 1,786.28 Cr and an expense ratio of 1.16%. 

Holding Analysis :   Nippon India Pharma Fund Growth Asset Allocation

The fund invests in the equity part and the slightest portion on others.  

Top Holding of the Firm :  

Let’s look at the top holdings of the firm : 

Stock Invested in Sector
sun pharmaceutical industries ltd pharmaceuticals
divis laboratories ltd pharmaceuticals
cipla ltd pharmaceuticals
dr. reddy’s laboratories limited pharmaceuticals
abbott india ltd pharmaceuticals
lupin ltd pharmaceuticals
fortis healthcare ltd hospital
syngene international ltd pharmaceuticals
aurobindo pharma ltd pharmaceuticals
alkem laboratories ltd hospital


“Are you looking to invest? How about opening your account with Gulaq & start investing? Get in touch.” 


*Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.



No votes yet.
Please wait...
Voting is currently disabled, data maintenance in progress.

Leave a Reply

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept